Jove
Visualize
Contact Us

Related Experiment Videos

Psoriatic arthritis.

R E Frank1

  • 1Nationwide Insurance Enterprise, Columbus, Ohio 43215-2220, USA.

Journal of Insurance Medicine (New York, N.Y.)
|October 28, 1999
PubMed
Summary
This summary is machine-generated.

Psoriatic arthritis, a type of psoriasis, is a seronegative spondyloarthropathy. Clinical and biochemical markers can predict its progression and potential impact on mortality.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Membranoproliferative glomerulonephritis.

Journal of insurance medicine (New York, N.Y.)·2005
Same author

Prostate cancer.

Journal of insurance medicine (New York, N.Y.)·2001
Same author

Approach scar revisions after self-inflicted wounds with caution.

Plastic and reconstructive surgery·2000
Same author

Myocardial bridging.

Journal of insurance medicine (New York, N.Y.)·1999
Same author

Supraventricular tachycardia vs. Marfan's syndrome.

Journal of insurance medicine (New York, N.Y.)·1996
Same author

Membranous nephropathy: case study.

Journal of insurance medicine (New York, N.Y.)·1995
Same journal

Creating Evidence-Based Ratings and Life Expectancies Medical Impairments.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

The Smoking Dilemma: A Technical Deep Dive.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Biological Clocks: Ready for Prime Time?

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

GLP-1 Therapies and Mortality Risk: Implications for Life Insurers.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Identifying Benzodiazepine Abuse: A Report of 3 Cases.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Between Fear and Adoption: The AI Paradox in Medico-Legal Practice Among National Insurance Physicians.

Journal of insurance medicine (New York, N.Y.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Rheumatology
  • Dermatology
  • Immunology

Background:

  • Psoriasis is a chronic inflammatory skin condition.
  • Psoriatic arthritis (PsA) is a distinct manifestation of psoriasis.
  • PsA is classified within the seronegative spondyloarthropathies.

Observation:

  • PsA involves joint inflammation and can affect various joints.
  • The condition shares features with other spondyloarthropathies.
  • The progression of PsA can be variable.

Findings:

  • Specific clinical markers are associated with PsA progression.
  • Biochemical markers also play a role in predicting PsA outcomes.
  • These markers can help identify patients at higher risk.

Implications:

  • Early identification of progression can guide treatment strategies.
  • Predictive markers may help manage patient prognosis.
  • Understanding these markers could potentially reduce adverse mortality effects.